Information1 | |
---|---|
Image | |
BRC No. | RBRC06239 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | C57BL/6-Siglec1<tm1(cre)Mtka> |
Former Common name | CD169-Cre, B6-Siglec1/Cre KI |
H-2 Haplotype | |
ES Cell line | |
Background strain | C57BL/6JJcl |
Appearance | |
Strain development | Developed by Dr. Masato Tanaka, Tokyo University of Pharmacy and Life Sciences, School of Life Science. B6JN/1 ES cells were used. C57BL/6 background. |
Strain description | CD169 (Siglec1) cre knock-in mice. iCre recombinase is expressed from CD169 locus. |
Colony maintenance | Homozygote x Homozygote [or crossing to C57BL/6JJcl] |
References | J. Am. Soc. Nephrol., 26, 896-906 (2015). 25266072 Nat. Commun., 6:7802 (2015). 26193821 Genesis, 32(1):19-26 (2002). 11835670 |
Health Report | |
---|---|
Examination Date / Room / Rack | 2023/03/13Room:3-2Rack:C 2022/12/12Room:3-2Rack:C 2022/09/12Room:3-2Rack:C 2022/06/13Room:3-2Rack:C 2022/03/14Room:3-2Rack:C 2021/12/14Room:3-2Rack:C 2021/12/10Room:3-2Rack:C 2021/09/13Room:3-2Rack:C 2021/06/14Room:3-2Rack:C |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Siglec1sialic acid binding Ig-like lectin 1, sialoadhesin2Siglec1<tm1(cre)Mtka>targeted mutation 1, Masato Tanaka Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter iCrephage P1 codon improved Cre (iCre)2iCre Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter neoneomycin resistance gene (E. coli)2mouse phosphoglycerate kinase promoter (PGK promoter) Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter polyoma virus polyA2 |
Information2 | |
---|---|
Donor DNA | Phage P1 improved Cre recombinase, mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, polyoma virus polyA, mouse Siglec1 genomic DNA |
Research application | Cre/loxP system Immunology and Inflammation Research |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR/DEVELOPER. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Am. Soc. Nephrol., 26, 896-906 (2015).In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE as a collaboration with the DEPOSITOR/DEVELOPER, and then include them as co-authors in any publications resulted by the use of the BIOLOGICAL RESOURCE. |
Depositor | Masato Tanaka (Tokyo University of Pharmacy and Life Sciences) |
Strain Status | ![]() ![]() ![]() |
Strain Availability | Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) Live mouse (1 to 3 months) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
Camara A, Cordeiro OG, Alloush F, Sponsel J, Chypre M, Onder L, Asano K, Tanaka M, Yagita H, Ludewig B, Flacher V, Mueller CG. Lymph Node Mesenchymal and Endothelial Stromal Cells Cooperate via the RANK-RANKL Cytokine Axis to Shape the Sinusoidal Macrophage Niche. Immunity 50(6) 1467-1481.e6(2019) 31201093 Camara A, Lavanant AC, Abe J, Desforges HL, Alexandre YO, Girardi E, Igamberdieva Z, Asano K, Tanaka M, Hehlgans T, Pfeffer K, Pfeffer S, Mueller SN, Stein JV, Mueller CG. CD169+ macrophages in lymph node and spleen critically depend on dual RANK and LTbetaR signaling. Proc Natl Acad Sci U S A 119(3) (2022) 35031565 |